Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Time Limit To Qualify For Stryker Rejuvenate, ABG II Modular-Neck Hip, According To LawyersandSettlements.Com Interview With Stewart Law Group
  • USA - English


News provided by

OnlineLegalMarketing.com

Dec 17, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Tampa, FL (PRWEB) December 17, 2014 -- The medical device manufacturer responsible for the Stryker Rejuvenate and/or ABG II Modular-Neck Hip Stem system recently agreed to a mediated settlement fund totaling over $1 billion* to compensate hip replacement patients having received the problematic hip replacement devices. As reported in The New York Times, (11/3/14) that fund, provided through Howmedica Osteonics Corporation, which does business as Stryker Orthopaedics, is based on an expectation of a $300,000 payout per hip implant for any patient who qualifies.

According to Bloomberg, the device maker faces more than 4,000 suits** consolidated in New Jersey state court and federal court in Minnesota. The New Jersey case is In Re Stryker Rejuvenate and ABG II Modular Hip Implant Litigation, 296 BER-L-936-13, Bergen County Superior Court. The federal case is In Re Stryker Rejuvenate Hip Implant Products Liability Litigation, 13-mdl-2441, U.S. District Court, District of Minnesota.

The deadline to submit an application is December 14th†. “We know there are people out there that should be benefiting from the settlement fund and have not yet come forward,” says Tampa-based attorney Ben Stewart of the Stewart Law Group in an interview with LawyersandSettlements.com. “It is only fair that they receive what is owed to them.”

Thousands** of hip replacement patients have been plagued with problems in recent years from the advent of new-age devices based upon, or containing various metal alloys initially thought to promote longevity of the replacement hip. However, according to the study published in The Journal of Bone & Joint Surgery, ("Adverse Local Tissue Reaction Arising from Corrosion at the Femoral Neck-Body Junction in a Dual-Taper Stem with a Cobalt-Chromium Modular Neck", May 2013) problems have been encountered with minute particles of metal entering the bloodstream and fostering a condition known as metallosis, which is toxic. Additionally, minute metal particles have been found to inflame surrounding soft tissue. In serious cases, the metal particles attack the cell walls, effectively breaking down and destroying soft tissue surrounding the joint.

The Stryker Rejuvenate and ABG systems contained a combination of a titanium-molybdenum-zirconium-iron alloy body paired with a modular cobalt-chromium alloy neck. The http://jbjs.org/content/95/10/865 [Journal of Bone and Joint Surgery __title__ ] (May 15, 2013) looked at 11 patients implanted with Stryker Rejuvenate/ABG II Modular-Neck Hip Stems and found that in every single case there was evidence of damage to the soft tissue.***

Stryker recalled the problematic implants in July, 2012**.

According to Bloomberg, the Qualified Settlement Fund provides a base payment of $300,000 per failed implant, with additional compensation available for patients who may have encountered complications during revision surgery**. Attorney Stewart's office is currently handling claims for many of those affected. “You don’t have to make a claim or sue,” Stewart says. “You just have to contact us and make an application; but be quick because there is a deadline coming.”

An article from the New Jersey Law Review states the requirements necessary for claimants to qualify for compensation.† Qualifying patients must possess the product label from their Stryker Rejuvenate or ABG implant. Such labels are available and retained as a permanent record at the facility where the implant surgery was initially performed. “There is a sticker that comes hermetically sealed in a little bag,” says Stewart. “That sticker is peeled off and attached to the surgical records. Just tell us which hospital did the implant and we can get the labels. You need the label off the implant to prove you have one of the [implants] covered by the settlement. That is available from the surgical center where you had the implant. They are required by law to keep these forever. We are very accustomed to obtaining these labels for people and filing the paperwork.”

The Stewart Law group is based in Tampa, Florida. The settlement is dated November 3rd of this year, which means only patients who underwent surgery prior to November 3rd qualify for the funding.

The deadline is December 14, 2014†.

  • "Stryker Settles Suits by Hip Implant Patients for $1 Billion", The New York Times, Nov. 3, 2014, nytimes.com/2014/11/04/business/stryker-settles-suits-by-hip-implant-patients-for-dollar1-billion.html?_r=0

**"Stryker to Pay More Than $1 Billion for Recalled Devices", Bloomberg, Nov. 4, 2014, bloomberg.com/news/2014-11-03/stryker-to-pay-more-than-1-billion-for-recalled-devices.html
*** Adverse Local Tissue Reaction Arising from Corrosion at the Femoral Neck-Body Junction in a Dual-Taper Stem with a Cobalt-Chromium Modular Neck - H. John Cooper, MD; Robert M. Urban, PhD; Richard L. Wixson, MD; R. Michael Meneghini, MD; Joshua J. Jacobs, MD The Journal of Bone & Joint Surgery J Bone Joint Surg Am, 2013 May 15;95(10):865-872. dx.doi.org/10.2106/JBJS.L.01042
†"$1B Settlement Reached in Stryker Hip-Implant Mass Tort", New Jersey Law Review, Nov. 10, 2014, rkmc.com/~/media/PDFs/NJLJ%20Stryker%20Settlement.pdf

LawyersandSettlements.com provides comprehensive legal news and critical information for those affected by once-in-a-lifetime situations involving medical device lawsuits, personal injury, defective products, California Overtime and labor issues or a host of others. Readers seeking legal help can request it by completing a form which is distributed to attorneys specializing in these cases. Trial attorneys utilize the site to keep abreast of hot legal issues and settlements as well as connect with potential clients.
Web: http://www.LawyersandSettlements.com.

About Online Legal Media

Online Legal Media owns and operates websites providing information for the general public and the legal community. LawyersandSettlements.com, founded in 2001, is an online legal news publication with over 2.1 million visitors annually and hundreds of thousands of requests for attorney help from its readership. OnlineLegalMarketing.com serves as a portal for trial attorneys to network and market their firms to other legal professionals. HealthEffectsOfAsbestos.com offers resources for those suffering from asbestos exposure and mesothelioma. Online Legal Media is based in Santa Cruz, California.

Follow Online Legal Media on Twitter @OnlineLegalNews and on Facebook at http://www.facebook.com/pages/LawyersAndSettlementscom/74380229132.

All trademarks are the property of their respective owners.

John Sliney. COO, OnlineLegalMarketing.com, http://www.lawyersandsettlements.com, +1 (831) 459-7799, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.